Internet-based aftercare for eating disorders following inpatient treatment: randomized controlled trial for bulimia nervosa

Not Applicable

Completed

Conditions: Bulimia nervosa (eating disorders)
Mental and Behavioural Disorders
Bulimia nervosa

Registration Number: ISRCTN08870215

Lead Sponsor: Federal Ministry of Education and Research (Germany)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: Female

Target Recruitment: 258

Inclusion Criteria

1. Age at least 16 years
2. Informed consent by patient and - if necessary - by her legal guardian
3. Female
4. Diagnosis of bulimia nervosa (BN) according to DSM-IV-TR at the time of admission to inpatient treatment
5. Successful completion of inpatient treatment as defined by at least 50% reduction in binge eating and purging during the last two weeks prior to discharge from inpatient treatment

Exclusion Criteria

1. Mental or physical condition that does not allow the patient's participation in the trial
2. Acute psychosis, chronic organic or schizophrenic psychosis
3. Severe suicidal ideation or behaviour
4. Premature discharge from inpatient treatment

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measures as of 17/04/2014, according to the study protocol approved in July 2007:<br>The primary efficacy endpoint will be the percentage of patients abstinent from core bulimia nervosa behaviors at the end of the treatment (9 months). Abstinence is defined as the absence of binge eating and inappropriate compensatory behaviour (e.g., vomiting) for at least two months at post-intervention. <br><br>Previous primary outcome measures:<br>The primary efficacy endpoint will be the frequency of relapses at the end of the treatment (12 month). Relapses are defined as the presence of binging and/or inappropriate compensatory behaviour (i.e. including vomiting) at least twice per week for three months during the 12 month follow-up.

Secondary Outcome Measures